Fiscal Year: January - December
Colgate-Palmolive Company (CL), listed on the NYSE, has a market capitalization of $. As of Oct 03, 2025, the stock is trading at $78.00 per share, offering investors a clear view of its current market value. Colgate-Palmolive Company is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 21.91, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Colgate-Palmolive Company also offers a dividend yield of 2.67%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Colgate-Palmolive Company (CL) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Colgate-Palmolive Company is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Colgate-Palmolive Company, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Colgate-Palmolive Company is 18.85, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Colgate-Palmolive Company (CL) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Colgate-Palmolive Company (CL) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Colgate-Palmolive Company (CL) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Colgate-Palmolive Company. To access the full SS Score, consider upgrading your subscription.
Colgate-Palmolive Company is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 21.91. Investors should compare these metrics with industry peers to gauge whether Colgate-Palmolive Company is outperforming or underperforming within its sector.
CNBC's “Halftime Report” team break down some of their recent stock action and the calls of the day.
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company announced today that Colgate Women's Games (CWG), the nation's longest-running indoor track and field series for girls and women, has officially ki...
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristoc...
Colgate-Palmolive stock (NYSE: CL) has decreased by 12% this year, lagging behind the S&P 500, which has risen by 13%. This drop is primarily attributed to various factors, such as slowing sales growt...
Colgate-Palmolive remains a global leader in oral care, boasting strong brand equity, innovation, and a 62-year dividend growth streak. CL demonstrates resilience amid inflation, with robust margins, ...
Bloomberg Intelligence highlights 50 Companies to Watch for 2025, focusing on catalysts like leadership changes, M&A, and sector trends such as AI and EVs. Dogcatcher analysis identifies 13 dividend-p...
Colgate-Palmolive Company is upgraded to Buy for the first time in more than two years as shares reach the targeted accumulation range of $81-82. CL's defensive business model, resilient pricing power...
Colgate-Palmolive will introduce new packaging and marketing for its toothpaste products, after Texas Attorney General Ken Paxton expressed concern that its marketing of fluoride could harm parents an...
The Board of Directors of Colgate-Palmolive today declared a quarterly cash dividend of $0.52 per common share, payable on November 14, 2025, to shareholders of record on October 17, 2025. The Company...
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on November 14, 2025, to shareholde...
Colgate-Palmolive Company (NYSE:CL) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 9:00 AM EDT Company Participants Noel Wallace - Chairman, CEO & President Conference...
Colgate-Palmolive agreed to pay $332 million to settle a long-running class-action lawsuit accusing the consumer products company of making mistakes in calculating its employees' pensions.
Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A...
I focus on 14 'safer' dividend stocks from Bloomberg's 50 Companies to Watch, where free cash flow yield exceeds dividend yield, signaling strong sustainability. Five 'IDEAL' stocks—China Hongqiao, IT...
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, will present on Wednesday, September 3, 2025 at 9:00 a.m. ET at the Barclays 2025 Global Consumer Stap...
July saw strong market gains, especially in tech, but finding bargains is tough as indices approach all-time highs. I focused July investments on high-yield BDCs like OBDC, MFIC, and BXSL, maintaining...
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Colgate-Palmolive Company CL posted better-than-expected second-quarter earnings on Friday.
Colgate-Palmolive Company (NYSE:CL) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer and Executive VP of M&A Noel R. Wal...
Colgate-Palmolive beat first-quarter sales and profit estimates on Friday, as resilient demand for its essentials such as oral and personal care products overcame rising prices and tariff uncertaintie...
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales GAAP EPS in...
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company announced today that Colgate Women's Games, the nation's longest-running indoor Track & Field series for girls and women, will return this December...
Bloomberg's 50 Companies to Watch leverages catalysts like new leadership, AI, and policy shifts to identify high-potential stocks for 2025. Yield-based 'dogcatcher' analysis spotlights 15 dividend pa...
14 Dividend Kings continue to outperform the S&P 500 in 2025. Dividend growth remains healthy, with one recent increase and a collective 2025 growth rate of 5.23%. Seventeen Dividend Kings currently a...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2025 | 3.46B | -2.44% | Est @-2.4% |
| 2026 | 3.37B | -2.50% | Analyst x4 |
| 2027 | 3.58B | 6.11% | Analyst x3 |
| 2028 | 4.00B | 11.82% | Analyst x1 |
| 2029 | 4.19B | 4.65% | Analyst x1 |
| 2030 | 4.31B | 2.89% | Est @2.9% |
| 2031 | 4.43B | 2.72% | Est @2.7% |
| 2032 | 4.54B | 2.59% | Est @2.6% |
| 2033 | 4.65B | 2.51% | Est @2.5% |
| 2034 | 4.76B | 2.29% | Est @2.3% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2023A | 3.04B | 1.00 | 3.04B |
| 2024A | 3.55B | 1.00 | 3.55B |
| 2025E | 3.46B | 1.08 | 3.21B |
| 2026E | 3.37B | 1.16 | 2.91B |
| 2027E | 3.58B | 1.25 | 2.87B |
| 2028E | 4.00B | 1.34 | 2.98B |
| 2029E | 4.19B | 1.45 | 2.89B |
| 2030E | 4.31B | 1.56 | 2.76B |
| 2031E | 4.43B | 1.68 | 2.64B |
| 2032E | 4.54B | 1.81 | 2.51B |
| 2033E | 4.65B | 1.95 | 2.39B |
| 2034E | 4.76B | 2.10 | 2.27B |
| Terminal | 94.18B | 2.10 | 44.93B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.
